Semaglutide is a GLP-1 receptor agonist, reducing appetite and aiding weight loss. Tirzepatide acts on both GLP-1 and GIP receptors, enhancing weight loss effects. Both help regulate blood sugar, control hunger, and support sustainable weight reduction.